Details for New Drug Application (NDA): 216291
✉ Email this page to a colleague
The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Summary for 216291
Tradename: | NEOSTIGMINE METHYLSULFATE |
Applicant: | Dr Reddys |
Ingredient: | neostigmine methylsulfate |
Patents: | 0 |
Pharmacology for NDA: 216291
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 216291
Suppliers and Packaging for NDA: 216291
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 216291 | ANDA | Dr.Reddys Laboratories Inc | 43598-945 | 43598-945-58 | 10 BLISTER PACK in 1 CARTON (43598-945-58) / 1 SYRINGE, GLASS in 1 BLISTER PACK (43598-945-11) / 3 mL in 1 SYRINGE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 3MG/3ML (1MG/ML) | ||||
Approval Date: | Jul 6, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription